| Liver transplantation for hepatocellular carcinoma: Hangzhou experiences SS Zheng, X Xu, J Wu, J Chen, WL Wang, M Zhang, TB Liang, LM Wu Transplantation 85 (12), 1726-1732, 2008 | 580 | 2008 |
| Targeting tumor-associated macrophages to synergize tumor immunotherapy X Xiang, J Wang, D Lu, X Xu Signal transduction and targeted therapy 6 (1), 75, 2021 | 448 | 2021 |
| Lactate clearance is a useful biomarker for the prediction of all-cause mortality in critically ill patients: a systematic review and meta-analysis Z Zhang, X Xu Critical care medicine 42 (9), 2118-2125, 2014 | 330 | 2014 |
| Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA Q Ye, S Ling, S Zheng, X Xu Molecular cancer 18, 1-13, 2019 | 293 | 2019 |
| Liver transplantation for hepatocellular carcinoma beyond the Milan criteria X Xu, D Lu, Q Ling, X Wei, J Wu, L Zhou, S Yan, L Wu, L Geng, Q Ke, ... Gut 65 (6), 1035-1041, 2016 | 222 | 2016 |
| Enhanced tumour penetration and prolonged circulation in blood of polyzwitterion–drug conjugates with cell-membrane affinity S Chen, Y Zhong, W Fan, J Xiang, G Wang, Q Zhou, J Wang, Y Geng, ... Nature Biomedical Engineering 5 (9), 1019-1037, 2021 | 184 | 2021 |
| YTH domain family 2 orchestrates epithelial-mesenchymal transition/proliferation dichotomy in pancreatic cancer cells J Chen, Y Sun, X Xu, D Wang, J He, H Zhou, Y Lu, J Zeng, F Du, A Gong, ... Cell cycle 16 (23), 2259-2271, 2017 | 183 | 2017 |
| NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma J Cheng, HY Xie, X Xu, J Wu, X Wei, R Su, W Zhang, Z Lv, S Zheng, ... Cancer letters 310 (1), 35-45, 2011 | 152 | 2011 |
| New generation nanomedicines constructed from self-assembling small-molecule prodrugs alleviate cancer drug toxicity H Wang, Z Lu, L Wang, T Guo, J Wu, J Wan, L Zhou, H Li, Z Li, D Jiang, ... Cancer research 77 (24), 6963-6974, 2017 | 142 | 2017 |
| USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation S Ling, Q Shan, Q Zhan, Q Ye, P Liu, S Xu, X He, J Ma, J Xiang, G Jiang, ... Gut 69 (7), 1322-1334, 2020 | 138 | 2020 |
| Self‐assembling prodrugs by precise programming of molecular structures that contribute distinct stability, pharmacokinetics, and antitumor efficacy H Wang, H Xie, J Wang, J Wu, X Ma, L Li, X Wei, Q Ling, P Song, L Zhou, ... Advanced Functional Materials 25 (31), 4956-4965, 2015 | 135 | 2015 |
| Effects of low central venous pressure during preanhepatic phase on blood loss and liver and renal function in liver transplantation ZY Feng, X Xu, SM Zhu, B Bein, SS Zheng World journal of surgery 34, 1864-1873, 2010 | 127 | 2010 |
| Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome c Q Ling, X Xu, X Wei, W Wang, B Zhou, B Wang, S Zheng Journal of Experimental & Clinical Cancer Research 30, 1-6, 2011 | 125 | 2011 |
| MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression Z Liu, J Li, J Chen, Q Shan, H Dai, H Xie, L Zhou, X Xu, S Zheng BMC cancer 18, 1-10, 2018 | 124 | 2018 |
| Attenuation of acute phase shear stress by somatostatin improves small‐for‐size liver graft survival X Xu, K Man, SS Zheng, TB Liang, TK Lee, KT Ng, ST Fan, CM Lo Liver transplantation 12 (4), 621-627, 2006 | 112 | 2006 |
| DLK1 as a potential target against cancer stem/progenitor cells of hepatocellular carcinoma X Xu, RF Liu, X Zhang, LY Huang, F Chen, QL Fei, ZG Han Molecular cancer therapeutics 11 (3), 629-638, 2012 | 109 | 2012 |
| Plasma heat shock protein 90alpha as a biomarker for the diagnosis of liver cancer: an official, large-scale, and multicenter clinical trial Y Fu, X Xu, D Huang, D Cui, L Liu, J Liu, Z He, J Liu, S Zheng, Y Luo EBioMedicine 24, 56-63, 2017 | 105 | 2017 |
| USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway S Ling, J Li, Q Shan, H Dai, D Lu, X Wen, P Song, H Xie, L Zhou, J Liu, ... Molecular oncology 11 (6), 682-695, 2017 | 105 | 2017 |
| Artificial liver support system combined with liver transplantation in the treatment of patients with acute-on-chronic liver failure X Xu, X Liu, Q Ling, Q Wei, Z Liu, X Xu, L Zhou, M Zhang, J Wu, J Huang, ... PloS one 8 (3), e58738, 2013 | 105 | 2013 |
| 3, 3′-Diindolylmethane stimulates exosomal Wnt11 autocrine signaling in human umbilical cord mesenchymal stem cells to enhance wound healing H Shi, X Xu, B Zhang, J Xu, Z Pan, A Gong, X Zhang, R Li, Y Sun, Y Yan, ... Theranostics 7 (6), 1674, 2017 | 97 | 2017 |
